Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000)

References

• Harris N L, Jaffe E S, Deibold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
   Google Scholar
• Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Can J Clin 2006; 56: 106–130
   PubMed Web of Science ®Google Scholar
• Naresh K N, Srinivas V, Soman C S. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using REAL, WHO Classifications. Ann Oncol 2000; 11(Suppl 1)S63–S67
   PubMed Web of Science ®Google Scholar
• Ko Y H, Kim C W, Park C S, Jang H K, Lee S S, Kim S H, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American Lymphoma. Cancer 1998; 83: 806–812
   PubMed Web of Science ®Google Scholar
• Sukpanichnant S, Sonakul D, Piankijagum A, Wanachiwanawin W, Veerakul G, Mahasandana C, et al. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer 1998; 83: 1197–1204
   PubMed Web of Science ®Google Scholar
• Shih L Y, Liang D C. Non-Hodgkin's lymphomas in Asia. Hematol Onc Clin North Am 1991; 5: 983–1001
   PubMed Web of Science ®Google Scholar
• Chang K C, Huang G C, Jones D, Tsao C J, Lee J Y, Su I J. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leuk Lymphoma 2004; 45: 1375–1384
   PubMed Web of Science ®Google Scholar
• Anderson J R, Armitage J O, Weisenburger D D. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographical locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998; 9: 717–720
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Intragumtornchai T, Wannakrairoj P, Chaimongkol B, Bhoopat L, Lekhakula A, Thamprasit T, et al. Non-Hodgkin's lymphoma in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer 1986; 78: 1813–1819
   Web of Science ®Google Scholar
• Lee S S, Cho K J, Kim C W, Kang Y K. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the Revised European-American classification of lymphoid neoplasms. Histopathology 1999; 35: 345–354
   PubMed Web of Science ®Google Scholar
• Kadin M E, Berard C W, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: proceedings of the United States – Japan seminar, September 6 and 7, in Seattle, Washington. Human Pathaol 1983; 14: 745–772
   PubMed Web of Science ®Google Scholar
• Ho F CS, Todd D, Loke S L, Ng R P, Khoo R K. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer 1984; 34: 143–148
   PubMed Web of Science ®Google Scholar
• Dinshaw K A, Ganesh B. Hospital Based Cancer Registry Annual Report 2001. Tata Memorial Hospital, Mumbai 2005
   Google Scholar
• Advani S H, Banavali S D, Agarwala S, Gopal R, Dinshaw K D, Borges A, et al. The pattern of malignant lymphoma in India: a study of 1371 cases. Leuk Lymphoma 1990; 2: 307–316
   PubMed Web of Science ®Google Scholar
• Naresh K N, Agarwal B, Sangal B C, Basu D D, Kothari A S, Soman C S. Regional variations in the distribution of subtypes of lymphoid neoplasms in India. Leuk Lymphoma 2002; 43: 1939–1943
   PubMed Web of Science ®Google Scholar
• Jones S E, Fuks Z, Bull M, Kadin M E, Dorfman R F, Kaplan H S, et al. Non-Hodgkin's lymphomas. IV. Clinicopathological correlation in 405 cases. Cancer 1973; 31: 806–823
   PubMed Web of Science ®Google Scholar
• Almasri N M, Habashneh M A, Khalidi H S. Non-Hodgkin's lymphoma in Jordon. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies. Saudi Med J 2004; 25: 609–614
   PubMed Web of Science ®Google Scholar
• Castella A, Joshi S, Raaschou T, Mason N. Pattern of malignant lymphoma in the United Arab Emirates – a histopathologic and immunologic study in 208 native patients. Acta Oncol 2001; 40: 660–664
   PubMed Web of Science ®Google Scholar
• Ahmad M, Khan A H, Mansoor A, Khan M A, Saeed S. Non-Hodgkin's lymphoma – clinicopathological pattern. J Pak Med Assoc 1992; 42: 205–207
   PubMedGoogle Scholar
• Ben-Ezra J, Burke J S, Swartz W G, Brownell M D, Brynes R K, Hill L R, et al. Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 1989; 73: 579–587
   PubMed Web of Science ®Google Scholar
• Dimopoulos M A, Alexanian R. Waldenstrom's macroglobulinemia. Blood 1994; 83: 1452–1459
   PubMed Web of Science ®Google Scholar
• Dimopoulos M A, Panayiotidis P, Moulopoulos L A, Sfikakis P, Dalakas M. Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000; 18: 214–226
   PubMed Web of Science ®Google Scholar
• Argatoff L H, Connors J M, Klasa R J, Horsman D E, Gascoyne R D. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997; 89: 2067–2078
   PubMed Web of Science ®Google Scholar
• Samaha H, Dumontet C, Kettere N, Moullet I, Thieblemont C, Bouafia F, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998; 12: 1281–1287
   PubMed Web of Science ®Google Scholar
• Bosch F, Lopez-Guillermo A, Campo E, Ribera J M, Conde E, Pris M A, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998; 82: 567–575
   PubMed Web of Science ®Google Scholar
• Velders G A, Kluin-Nelemans J C, De Boer C J, Hermans J, Noordijk E M, Schuuring E, et al. Mantle-cell lymphoma: a population based clinical study. J Clin Oncol 1996; 14: 1269–1274
   PubMed Web of Science ®Google Scholar
• Winberg C D, Nathwani B N, Bearman R M, Rappaport H. Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients. Cancer 1981; 48: 2223–2235
   PubMed Web of Science ®Google Scholar
• Martin A R, Weisenburger D D, Chan W C, Ruby E I, Anderson J R, Vose J M, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 1995; 85: 3671–3678
   PubMed Web of Science ®Google Scholar
• Miller T P, LeBlanc M, Grogan T M, Fisher R I. Follicular lymphomas: do histologic subtypes predict outcome?. Hematol Oncol Clin North Am 1997; 11: 893–900
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma: summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Berger F, Dumontet C, Moullet J, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802–806
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997; 15: 1624–1630
   PubMed Web of Science ®Google Scholar
• Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology (Am Soc Hematol Educ Program) 2005; 00: 307–313
   Google Scholar
• Engelhard M, Brittinger G, Huhn D, Gerhartz H H, Meusers P, Siegert W, et al. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 1997; 89: 2291–2297
   PubMed Web of Science ®Google Scholar
• Salar A, Fernandez de Sevilla A, Romagosa V, Domingo-Claros A, Gonzalez-Barca E, Pera J, et al. Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management?. Eur J Haematol 1998; 60: 202–208
   PubMed Web of Science ®Google Scholar
• Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005; 23: 2797–2804
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J. Lymphoma classification – from controversy to consensus: the REAL, WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11(Suppl 1)S3–S10
   PubMed Web of Science ®Google Scholar
• Simon R, Durrelman S, Hoppe R T, Bonadonna G, Bloomfield C D, Rudders R A, et al. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Long term follow-up of 1153 patients with non-Hodgkin's lymphomas. Ann Intern Med 1988; 109: 935–945
   PubMed Web of Science ®Google Scholar
• Bain B, Matutes E, Robinson D, Lampert I A, Brito-Babapulle V, Morilla R, et al. Leukemia as a manifestation of large cell lymphoma. Br J Haematol 1991; 77: 301–310
   PubMed Web of Science ®Google Scholar
• Michel R P, Case B W, Moinuddin M. Immunoblastic lymphosarcoma: a light, immunofluorescence, and electron microscopic study. Cancer 1979; 43: 224–236
   PubMed Web of Science ®Google Scholar
• Lichtenstein A, Levine A M, Lukes R J, Cramer A D, Taylor C R, Lincoln T L, et al. Immunoblastic sarcoma: a clinical description. Cancer 1979; 43: 343–352
   PubMed Web of Science ®Google Scholar
• Hutchison R E, Finch C, Kepner J, Fuller C, Bowman P, Link M, et al. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons. Ann Oncol 2000; 11(Suppl 1)S35–S38
   PubMed Web of Science ®Google Scholar
• Levine A M, Pavlova Z, Pockros A W, Parker J W, Teitelbaum A H, Paganini-Hill A, et al. Small non-cleaved follicular center cell (FCC) lymphoma: Burkitt and non-Burkitt variants in the United States. I. Clinical features. Cancer 1983; 52: 1073–1079
   PubMed Web of Science ®Google Scholar
• Braziel R M, Arber D A, Slovak M L, Gulley M L, Spier C, Kjeldsberg C, et al. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood 2001; 97: 3713–3720
   PubMed Web of Science ®Google Scholar
• Miliauskas J R, Berard C W, Young R C, Gravin A J, Edwards B K, DeVita V T, Jr. Undifferentiated non-Hodgkin's lymphomas (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction. Cancer 1982; 50: 2115–2121
   PubMed Web of Science ®Google Scholar
• Nathwani B N, Diamond L W, Winberg C D, Kim H, Bearman R M, Glick J H, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1981; 48: 2347–2357
   PubMed Web of Science ®Google Scholar
• Nathwani B N, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 1976; 38: 964–983
   PubMed Web of Science ®Google Scholar
• Kwong Y L, Chan A C, Liang R, Chiang A K, Chim C S, Chan T K, et al. CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997; 97: 821–829
   PubMed Web of Science ®Google Scholar
• Shaw P H, Cohn S L, Morgan E R, Kovarik P, Haut P R, Kletzel M, et al. Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literature. Cancer 2001; 91: 642–646
   PubMed Web of Science ®Google Scholar
• Greer J P, York J C, Cousar J B, Mitchell R T, Flexner J M, Collins R D, et al. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol 1984; 2: 788–798
   PubMed Web of Science ®Google Scholar
• Armitage J O, Greer J P, Levine A M, Weisenburger D D, Formenti S C, Bast M, et al. Peripheral T-cell lymphoma. Cancer 1989; 63: 158–163
   PubMed Web of Science ®Google Scholar
• Ansell S M, Habermann T M, Kurtin P J, Witzig T E, Chen M G, Li C Y, et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 1997; 15: 2296–2301
   PubMed Web of Science ®Google Scholar
• Lopez-Guillermo A, Cid J, Salar A, Lopez A, Montalban C, Castrillo J M, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL classification. Ann Oncol 1998; 9: 849–855
   PubMed Web of Science ®Google Scholar
• Melnyk A, Rodriguez A, Pugh W C, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of the immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89: 4514–4520
   PubMed Web of Science ®Google Scholar
• Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe M J, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998; 91: 2076–2084
   PubMed Web of Science ®Google Scholar
• Chott A, Kaserer K, Augustin L, Vesely M, Heinz R, Oehlinger W, Hanak H, Radaszkiewicz T. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 1990; 14: 439–448
   PubMed Web of Science ®Google Scholar
• Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, Berger F, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3727–3734
   PubMed Web of Science ®Google Scholar
• Kadin M E. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 1994; 5(Suppl 1)25–30
   PubMedGoogle Scholar
• Greer J P, Kinney M C, Collins R D, Salhany K E, Wolff S N, Hainsworth J D, et al. Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol 1991; 9: 539–547
   PubMed Web of Science ®Google Scholar
• Pileri S, Bocchia M, Baroni C D, Martelli M, Falini B, Sabattini E, et al. Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinicopathological study of 69 cases. Br J Haematol 1994; 86: 513–523
   PubMed Web of Science ®Google Scholar
• Kadin M E, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral adenopathy. Blood 1986; 68: 1042–1049
   PubMed Web of Science ®Google Scholar
• Bitter M A, Franklin W A, Larson R A, McKeitan T W, Rubin C M, Le Beau M M, et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305–316
   PubMed Web of Science ®Google Scholar
• Schnitzer B, Roth M S, Hyder D M, Ginsburg D. Ki-1 lymphomas in children. Cancer 1988; 61: 1213–1221
   PubMed Web of Science ®Google Scholar
• Chan J K, Ng C S, Hui P K, Leung T W, Lo E S, Lau W H, et al. Anaplastic large cell lymphoma. Delineation of two morphological types. Histopathology 1989; 15: 11–34
   PubMed Web of Science ®Google Scholar
• Agnarsson B A, Kadin M E. Ki-1-positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988; 12: 264–274
   PubMed Web of Science ®Google Scholar
• Filippa D A, Ladanyi M, Wollner N, Straus D J, O'Brien J P, Portlock C, et al. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 1996; 87: 2905–2917
   PubMed Web of Science ®Google Scholar
• Economopoulos T, Papageorgiou S, Dimopoulolos M A, Pavlidis N, Tsatalas C, Symeonidis A, et al. Non-Hodgkin's lymphoma in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases. Acta Haematol 2005; 113: 97–103
   PubMed Web of Science ®Google Scholar
• Huh J, Cho K, Heo D S, Kim J E, Kim C W. Detection of Epstein – Barr virus in Korean peripheral T-cell lymphoma. Am J Hematol 1999; 60: 205–214
   PubMed Web of Science ®Google Scholar
• Kim J E, Kim Y A, Jeon Y K, Park S S, Heo D S, Kim C W. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1. Pathol Int 2003; 53: 735–743
   PubMed Web of Science ®Google Scholar
• Lee S H, Su I J, Chen R L, Lin K S, Lin D T, Chuu W M, et al. A pathologic study of childhood lymphoma in Taiwan with special reference to peripheral T-cell lymphoma and the association with Epstein – Barr viral infection. Cancer 1991; 68: 1954–1962
   PubMed Web of Science ®Google Scholar